Antitumor efficacy of PARP inhibitors in homologous recombination deficient carcinomas. Yi T, Feng Y, Sundaram R, Tie Y, et al. Int J Cancer 2019;145:1209-1220.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yi T, Feng Y, Sundaram R, Tie Y, et al. Antitumor efficacy of PARP inhibitors in homologous recombination deficient carcinomas. Int J Cancer 2019;145:1209-1220.
PMID: 30666631